Laredo Health Department hosts FREE At-Home COVID-19 Tests

Translate to Spanish or other 102 languages!

The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center. Image for illustration purposes
The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center. Image for illustration purposes

Mega Doctor News

- Advertisement -

LAREDO, Texas— The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center.

WHO:            City of Laredo Health Department

WHAT:          FREE at-home COVID-19 Tests

- Advertisement -

WHEN:          Saturday, July 9, 2022, from 9:00 – 11:00 AM

WHERE:        Intersection of Guadalupe and Meadow

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -